• Je něco špatně v tomto záznamu ?

Quantitative analysis of volatile metabolites released in vitro by bacteria of the genus Stenotrophomonas for identification of breath biomarkers of respiratory infection in cystic fibrosis

V. Shestivska, K. Dryahina, J. Nunvář, K. Sovová, D. Elhottová, A. Nemec, D. Smith, P. Španěl,

. 2015 ; 9 (2) : 027104. [pub] 20150401

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc16000184

The aim of the present study was to characterize the volatile metabolites produced by genotypically diverse strains of the Stenotrophomonas genus in order to evaluate their potential as biomarkers of lung infection by non-invasive breath analysis. Volatile organic compounds (VOCs) emitted from 15 clinical and five environmental strains belonging to different genogroups of Stenotrophomonas maltophilia (n = 18) and Stenotrophomonas rhizophila (n = 2) cultured in Mueller-Hinton Broth (MHB) liquid media were analysed by gas chromatography mass spectrometry (GC-MS) and selected ion flow tube mass spectrometry (SIFT-MS). Several VOCs were detected in high concentration, including ammonia, propanol, dimethyl disulphide propanol and dimethyl disulphide. The GC-MS measurements showed that all 15 clinical strains produced similar headspace VOCs compositions, and SIFT-MS quantification showed that the rates of production of the VOCs by the genotypically distinct strains were very similar. All in vitro cultures of both the Stenotrophomonas species were characterised by efficient production of two isomers of methyl butanol, which can be described by known biochemical pathways and which is absent in other pathogens, including Pseudomonas aeruginosa. These in-vitro data indicate that methyl butanol isomers may be exhaled breath biomarkers of S. maltophilia lung infection in patients with cystic fibrosis.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc16000184
003      
CZ-PrNML
005      
20200121084554.0
007      
ta
008      
160108s2015 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1088/1752-7155/9/2/027104 $2 doi
035    __
$a (PubMed)25830686
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Shestivska, Violetta $u J Heyrovsky Institute of Physical Chemistry, Academy of Sciences of the Czech Republic, Dolejškova 3, 18223 Prague 8, Czech Republic.
245    10
$a Quantitative analysis of volatile metabolites released in vitro by bacteria of the genus Stenotrophomonas for identification of breath biomarkers of respiratory infection in cystic fibrosis / $c V. Shestivska, K. Dryahina, J. Nunvář, K. Sovová, D. Elhottová, A. Nemec, D. Smith, P. Španěl,
520    9_
$a The aim of the present study was to characterize the volatile metabolites produced by genotypically diverse strains of the Stenotrophomonas genus in order to evaluate their potential as biomarkers of lung infection by non-invasive breath analysis. Volatile organic compounds (VOCs) emitted from 15 clinical and five environmental strains belonging to different genogroups of Stenotrophomonas maltophilia (n = 18) and Stenotrophomonas rhizophila (n = 2) cultured in Mueller-Hinton Broth (MHB) liquid media were analysed by gas chromatography mass spectrometry (GC-MS) and selected ion flow tube mass spectrometry (SIFT-MS). Several VOCs were detected in high concentration, including ammonia, propanol, dimethyl disulphide propanol and dimethyl disulphide. The GC-MS measurements showed that all 15 clinical strains produced similar headspace VOCs compositions, and SIFT-MS quantification showed that the rates of production of the VOCs by the genotypically distinct strains were very similar. All in vitro cultures of both the Stenotrophomonas species were characterised by efficient production of two isomers of methyl butanol, which can be described by known biochemical pathways and which is absent in other pathogens, including Pseudomonas aeruginosa. These in-vitro data indicate that methyl butanol isomers may be exhaled breath biomarkers of S. maltophilia lung infection in patients with cystic fibrosis.
650    _2
$a 1-propanol $x analýza $x metabolismus $7 D000433
650    _2
$a amoniak $x analýza $x metabolismus $7 D000641
650    _2
$a biologické markery $x analýza $7 D015415
650    _2
$a dechové testy $x metody $7 D001944
650    _2
$a cystická fibróza $x komplikace $7 D003550
650    _2
$a disulfidy $x analýza $x metabolismus $7 D004220
650    _2
$a plynová chromatografie s hmotnostně spektrometrickou detekcí $7 D008401
650    _2
$a genotyp $7 D005838
650    _2
$a gramnegativní bakteriální infekce $x komplikace $x diagnóza $x metabolismus $7 D016905
650    _2
$a lidé $7 D006801
650    _2
$a techniky in vitro $7 D066298
650    _2
$a hmotnostní spektrometrie $x metody $7 D013058
650    _2
$a infekce dýchací soustavy $x komplikace $x diagnóza $x metabolismus $7 D012141
650    _2
$a Stenotrophomonas $x chemie $x metabolismus $7 D020588
650    _2
$a těkavé organické sloučeniny $x analýza $x metabolismus $7 D055549
655    _2
$a časopisecké články $7 D016428
700    1_
$a Dryahina, Kseniya
700    1_
$a Nunvář, Jaroslav
700    1_
$a Sovová, Kristýna
700    1_
$a Elhottová, Dana
700    1_
$a Nemec, Alexandr
700    1_
$a Smith, David
700    1_
$a Španěl, Patrik
773    0_
$w MED00182181 $t Journal of breath research $x 1752-7163 $g Roč. 9, č. 2 (2015), s. 027104
856    41
$u https://pubmed.ncbi.nlm.nih.gov/25830686 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20160108 $b ABA008
991    __
$a 20200121084931 $b ABA008
999    __
$a ok $b bmc $g 1102465 $s 924390
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2015 $b 9 $c 2 $d 027104 $e 20150401 $i 1752-7163 $m Journal of breath research $n J Breath Res $x MED00182181
LZP    __
$a Pubmed-20160108

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace